Abstract | BACKGROUND: MATERIAL/METHODS: RESULTS: Ten patients were men (40.0%). Median age of recipients at transplantation was 29.0 (17-51) years. Eighteen patients (72%) had evidence of myeloproliferation, 1 had paroxysmal nocturnal hemoglobinuria, and 6 had idiopathic disease. In 55.5% of cases eventually diagnosed with myeloproliferative neoplasms, Budd-Chiari syndrome was their initial presentation. All patients were maintained on long-term post-transplant anticoagulation protocol. The median follow-up time was 58.8 months. Four patients (16%) died during follow-up. Acute graft rejection occurred in 16% of cases. During the observation period, 5 patients had recurrent thrombotic events. The 5-year patient and graft survival rate was 84%. No case of transformation to acute leukemia was seen. CONCLUSIONS: Our data show satisfactory long-term survival of patients and grafts in the study group. Occult course of myeloproliferative neoplasms is frequent in this population and exceeds 50%. We observed recurrent thrombosis in 20% of recipients.
|
Authors | Urszula Oldakowska-Jedynak, Mateusz Ziarkiewicz, Bogna Ziarkiewicz-Wróblewska, Jadwiga Dwilewicz-Trojaczek, Barbara Górnicka, Paweł Nyckowski, Rafał Paluszkiewicz, Tadeusz Wróblewski, Krzysztof Zieniewicz, Waldemar Patkowski, Leszek Pączek, Wiesław Wiktor Jedrzejczak, Marek Krawczyk |
Journal | Annals of transplantation
(Ann Transplant)
Vol. 19
Pg. 591-7
(Nov 14 2014)
ISSN: 2329-0358 [Electronic] United States |
PMID | 25394736
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adolescent
- Adult
- Budd-Chiari Syndrome
(etiology, surgery)
- Female
- Follow-Up Studies
- Graft Rejection
(epidemiology)
- Graft Survival
- Humans
- Liver Transplantation
- Male
- Middle Aged
- Myeloproliferative Disorders
(complications)
- Postoperative Complications
- Recurrence
- Retrospective Studies
- Thrombosis
(complications)
- Treatment Outcome
- Young Adult
|